Vogt Anne B, Spindeldreher Sebastian, Kropshofer Harald
Roche Center for Medical Genomics, F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
Immunol Rev. 2002 Nov;189:136-51. doi: 10.1034/j.1600-065x.2002.18912.x.
Protein reorganization at the interface of a T cell and an antigen-presenting cell (APC) plays an important role in T cell activation. Imaging techniques reveal that reorganization of particular receptor-ligand pairs gives rise to an intercellular junction, termed the immunological synapse. In this synapse antigenic peptides associated with major histocompatibility complex (MHC) molecules form multimolecular arrays on the APC side, engaging an equivalent number of clustered T cell receptors (TCRs) on the T cell. The accumulation of MHC molecules carrying cognate peptide in the APC-T cell interface was thought to depend on the specificity and presence of TCRs. Recent evidence, however, suggests that the APC is equipped to preorganize MHC-peptide complexes in the absence of T cells. To this end, MHC molecules become incorporated into two types of membrane microdomains: (i) cholesterol- and glycosphingolipid-enriched domains, denoted lipid rafts, that preconcentrate MHC class II molecules; and (ii) microdomains made up of tetraspan proteins, such as CD9, CD63, CD81 or CD82, that mediate enrichment of MHC class II molecules loaded with a select set of peptides. It follows that the integrity, composition and dynamics of these microdomains are candidate determinants favoring activation or silencing of T cells.
T细胞与抗原呈递细胞(APC)界面处的蛋白质重组在T细胞活化中起重要作用。成像技术显示,特定受体-配体对的重组会形成一种细胞间连接,称为免疫突触。在这个突触中,与主要组织相容性复合体(MHC)分子相关的抗原肽在APC一侧形成多分子阵列,与T细胞上同等数量的聚集T细胞受体(TCR)结合。人们认为,在APC-T细胞界面中携带同源肽的MHC分子的积累取决于TCR的特异性和存在情况。然而,最近的证据表明,APC能够在没有T细胞的情况下预先组织MHC-肽复合物。为此,MHC分子会整合到两种类型的膜微区中:(i)富含胆固醇和糖鞘脂的结构域,称为脂筏,其会预先浓缩II类MHC分子;(ii)由四跨膜蛋白组成的微区,如CD9、CD63、CD81或CD82,其介导装载特定一组肽的II类MHC分子的富集。因此,这些微区的完整性、组成和动态变化是有利于T细胞活化或沉默的候选决定因素。